AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta).
Ratings
4.5 / 5
11 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Richard A. Gonzalez$321.7B
Market Cap • 25/07/20242012
(há 12 anos)
2012
(12 years ago)
NYSE
ListagemS&P500 Participant
Index Composite • 2024
North Chicago
Sede • Illinois50.000
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ABBVSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.